OneVue Holdings (OVH)

Size: px
Start display at page:

Download "OneVue Holdings (OVH)"

Transcription

1 7 August 2017 Analyst Lafitani Sotiriou Associate Analyst James Filius Authorisation TS Lim OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation Buy (unchanged) Price $0.56 Target (12 months) $0.95 (previously $0.98) GICS Sector Diversified Financials Expected Return Capital growth 69.6% Dividend yield 0.0% Total expected return 69.6% Company Data & Ratios Enterprise value Market cap $128.9m $147.5m Issued capital 263.3m Free float 87% Avg. daily val. (52wk) $181, month price range $0.47-$0.715 Price Performance (1m) (3m) (12m) Price (A$) Absolute (%) Rel market (%) Looking to FY17 result show cost-out progress OVH is set to release its FY17 result on Monday, 28 August, where we expect the company to deliver a profitable full year result and for evidence of the $4m pre-tax cost out program to show. We are forecasting underlying EBITDA of $4.5m for FY17e, with 2H17e including a full period contribution from the DVA merger. Further, in the recent quarterly update OVH displayed growth in three of the four divisions, with Super Trustee Services being flat over the quarter due to a lost client (however the division Funds Under Trusteeship still grew 21% over the year). A highlight of the update includes Platform Services netflows of $154m compared to our $140m estimate, (up 52% vs pcp), and Fund Services unit registry business growing 19% over the last year (when using FUA as a measurement). OVH has flagged it anticipates doubling the unit registry business over the years ahead (based on contracted business). June quarter highlights Below are OVH s June quarter highlights: Fund Services Unit Registry FUA up 5.1% over the quarter to $489.1 billion; Super Services FUA up 8.2% over the quarter to $1,956m; Platform Services FUA up 2.8% over the quarter to $4.0 billion; Platform Services net-flows of $154m (up 52% vs pcp); and Super Trustee Services FUT flat over the quarter at $9.4 billion. Earnings revisions Following the quarterly update we have trimmed our underlying EPS by -1.3%, -3.5%, and -0.9% for FY17, FY18 and FY19 respectively. The adjustment is largely driven by the lost client in Super Trustee Services. Following the changes our revised Price Target is $0.95 per share (previously $0.98), with our Buy recommendation remaining unchanged. Absolute Price $1.00 $0.90 $0.80 $0.70 $0.60 $0.50 $0.40 $0.30 Aug 15 Feb 16 Aug 16 Feb 17 Aug 17 SOURCE: IRESS OVH S&P 300 Rebased BELL POTTER SECURITIES LIMITED ABN AFSL Earnings Forecast Year end June e 2018e 2019e Revenue (A$m) Underlying EBITDA (A$m) NPAT (reported) $m NPAT (underlying) $m EPS (underlying) (cps) EPS growth (%) 200% 46% Underlying PER (x) Price/CF (x) EV/EBITDA (x) Dividend ( ps) Yield (%) 0.0% 0.0% 0.0% 5.0% ROE (%) -13.3% 3.6% 8.0% 10.9% Franking (%) na na na 0.0% SOURCE: BELL POTTER SECURITIES ESTIMATES DISCLAIMER: THIS REPORT MUST BE READ WITH THE DISCLAIMER ON PAGE 7 THAT FORMS PART OF IT. Page 1

2 Net-flows and other estimates Figure 1 - Quarterly Platform Services net-flow and FUA estimates OneVue Holdings (OVH) FY15 1Q 2Q 3Q 4Q FY16 1Q 2Q 3Q 4Q FY17 1Qe 2Qe 3Qe 4Qe FY18e Jun-15 Sep-15 Dec-15 Mar-16 Jun-16 Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Jun-18 Platform Services FUA ($m) Opening Retail FUA 1,940 3,075 3,094 3,252 3,158 3,075 3,289 3,252 3,781 3,907 3,289 4,018 4,210 4,405 4,580 4,018 Market and other Net-flow s Closing Retail FUA 3,075 3,094 3,252 3,158 3,289 3,289 3,252 3,781 3,907 4,018 4,018 4,210 4,405 4,580 4,809 4,809 7% 5% 16% 24% 22% 22% 29% 17% 17% 20% 20% Closing FUA 3,075 3,094 3,252 3,158 3,289 3,289 3,252 3,781 3,907 4,018 4,018 4,210 4,405 4,580 4,809 4,809 Average FUA 2,711 3,140 3,233 3,174 3,441 3,902 3,649 4,211 4,598 4,404 Super Trustee Services FUT ($m)* Super Trustee Closing FUT ($m) 6,493 6,994 7,200 7,796 7,796 8,439 8,882 9,436 9,401 9,401 9,871 10,365 10,883 11,427 11,427 Grow th vs pcp 30% 27% 31% 21% 21% 17% 17% 15% 22% 22% Average FUT 8,372 9,240 8,791 9,879 10,891 10,389 *Acquired in October 2016 Figure 2 - Platform Services FUA growth ($m) 5,000 4,500 4,000 3,500 3,000 2,500 2,000 1,500 1, Figure 3 - Platform Services quarterly net-flows ($m) Figure 4 - Super Trustee Services FUT ($m) 11,000 10,000 9,000 8,000 7,000 6,000 5,000 4,000 Figure 5 - Fund Services Unit Registry FUA ($ billion) Sep-15 Dec-15 Mar-16 Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Page 2

3 OneVue Holdings Overview Company Description OneVue (OVH) is an emerging financial services technology company leveraged to the burgeoning superannuation system in Australia. The company has grown since 2007 through selective bolt-on acquisitions coupled with its own Research and Development to create the company that we see today. The company has carved out its niche as a trusted provided of back-and-middle office administration with deep multi-year and multi-faceted relationships across the financial services industry. OVH is split into three divisions as highlighted below: 1 Fund Services. OVH provides back/middle office solutions for investment managers, custodians and trustees via a full service outsourced unit registry, or by providing its installed software via a licence fee. Following the recent acquisition of Select Group, the Fund Services division now provides Responsible Entity (RE) and trustee services, which complements the existing offering. 2 Platform Services. OVH is an Investment Platform provider with closing retail FUA over $3 billion at the end of September The key segments of retail super, SMSF and IDPS are covered, in addition to next-generation capabilities surrounding SMA/Managed Accounts and with strong web solutions for the digital investor. Following the Select Group acquisition the Platform Services division provides investment management and implemented portfolio consulting services (which includes a fund-of-fund manager). 3 Super Services. OVH provides third party administration services to the superannuation industry. These services include data management, member communication, as well as contribution and benefit payment processing. OVH entered Superannuation Administration with the November 2015 acquisition of Super Managers Australia Pty Ltd (SMA), a business with over 22,000 members and FUA in excess of $1.1 billion. OVH acquired Diversa (DVA) in October Investment strategy We believe Australia has a key competitive advantage in the provision of financial technology solutions given our large superannuation sector and educated workforce. We believe one of the emerging stars is OVH, given its technology and automation focus and its market positioning. Risks Forecast growth not realised There is a risk that the projections provided by OneVue are not realised; Increased Competition risk OneVue operates in a competitive market landscape and is exposed to the possibility of increased risk; Regulatory risk - OneVue is regulated by multiple agencies and any changes in the regulatory regimes under which it operates may affect the financial performance and capital requirements of the group; Market risk A prolonged recession, economic crisis/shock, or other factors that may lead to a sustained weak market environment have the ability to adversely affect the earnings potential of the company. In addition, being a listed stock, the share price may be subject to volatility and fluctuations in price from time to time; Page 3

4 Technology risk There is a risk that existing technologies that OneVue provides will be superseded or made redundant by new technologies or players in the market. Further there is a risk that there may be a failure in software or systems that OneVue relies on; Operational risk The operation of OneVue may be affected by various factors, including failures in internal controls. The clients of OneVue would be particularly sensitive to any operational issues; Key client risk The departure of a major client could cause a loss of earnings to OneVue. By contrast, any major client win would be seen as a positive catalyst. OneVue has no client that represents more than 12% of revenue; Key person risk Similar to other small capitalised stocks, the loss of any key staff may be detrimental to OneVue; and Risk associated with acquisitions OneVue has acquired many businesses in the last three years and is expecting to make further acquisitions. Each acquisition brings with it execution, reputational, pricing risk and a variety of other issues including all stakeholder satisfaction. Page 4

5 Interim earnings Figure 6 - Interim earnings INTERIM INCOME STATEMENT Y/e June 30 ($m) H16 2H H17 2H17e 2017e 1H18e 2H18e 2018e 1H19e 2H19e 2019e Sales revenue EBITDA Depreciation & Amortisation EBIT Net Interest Pre-tax profit Tax R&D tax incentive receipt Operating NPAT One-off items Reported net profit Cash NPAT SEGMENTALS FUND SERVICES ($M) H16 2H H17 2H17e 2017e 1H18e 2H18e 2018e 1H19e 2H19e 2019e Total Unit Registry Services revenue Total Superannuation Services Revenue Total Fund Services Revenue One-off revenue items Underlying Fund Services Revenue Total expenses of which one-off expenses Total underlying expenses Underying EBITDA Reported EBITDA PLATFORM SERVICES ($M) H16 2H H17 2H17e 2017e 1H18e 2H18e 2018e 1H19e 2H19e 2019e Total Platform Services revenue One-off revenue items Total underlying Platform Services revenue Closing FUA $m 3,075 3,252 3,289 3,289 3,781 4,018 4,018 4,405 4,809 4,809 5,237 5,682 5,682 Average FUA $m 2,711 3,140 3,233 3,174 3,441 3,902 3,649 4,211 4,598 4,404 5,022 5,450 5,236 Average margin (bps) Total expenses of which one-off expenses Total underlying expenses Underying EBITDA Reported EBITDA SUPERANNUATION TRUSTEE SERVICES ($M) H16 2H H17 2H17e 2017e 1H18e 2H18e 2018e 1H19e 2H19e 2019e Total Super Trustee Services Revenue One-off revenue items Total underlying Super Trustee Services revenue Total expenses of which one-off expenses Total underlying expenses Underying EBITDA Reported EBITDA Remaining DVA synergies CORPORATE ($M) H16 2H H17 2H17e 2017e 1H18e 2H18e 2018e 1H19e 2H19e 2019e Revenue of which are one-off revenue items Underlying Corporate revenue Expenses of which one-off expenses Total underlying Corporate expenses Underlying EBITDA Reported EBITDA Page 5

6 OneVue Holdings as at 7 August 2017 Recommendation Buy Price $0.56 Target (12 months) $0.95 OneVue Holdings (OVH) 7 August 2017 Table 1 - Financial summary OneVue (OVH) Price Target (A$) 0.95 Share Price (A$) 0.56 Recommendation: Buy Market Cap (A$m) INCOME STATEMENT VALUATION DATA Y/e June 30 ($m) e 2018e 2019e Y/e June 30 ($m) e 2018e 2019e Sales revenue Underlying NPAT ($m) Operating Expenses Underlying EPS (c) EBITDA Underlying EPS growth (%) 200% 46% Depreciation & Amortisation Underlying P/E ratio (x) EBIT CFPS (c) Net Interest Price/CF (x) Pre-tax profit DPS (c) Tax Yield (%) 0.0% 0.0% 0.0% 0.0% 5.0% R&D tax refund Franking (%) na na na na 0% Operating NPAT EV/EBITDA (x) One-off items Price/book (x) Reported net profit NTA ($) Underlying NPAT Cash NPAT* PROFITABILITY RATIOS Y/e June 30 ($m) e 2018e 2019e CASHFLOW EBIT/sales (%) -6% -15% 1% 15% 21% Y/e June 30 ($m) e 2018e 2019e Return on assets (%) -7% -11% 1% 7% 10% EBITDA Return on equity (%) -3% -13% 4% 8% 11% Change in provisions Dividend cover (x) na na na na 1.4 Working capital change Effective tax rate (%) 0% 0% na 0% 17% Net interest Tax paid LIQUIDITY AND LEVERAGE RATIOS Other Y/e June 30 ($m) e 2018e 2019e Operating cashflow Net debt/(cash) ($m) Capex Net debt/equity (%) -40% -51% -22% -30% -36% Investments Current ratio (x) Asset sales Other INTERIMS Free cash flow Half end December 31 ($m) 1H16 1H17 1H18e 1H19e 1H20e Change in borrowings Sales revenue Equity raised (net) EBIT Dividends paid Pre tax profit Other Adjusted profit Financing cashflow One-off items Net change in cash Reported profit Cash at end of period Interim DPS (cents) BALANCE SHEET SEGMENTALS Y/e June 30 ($m) e 2018e 2019e Y/e June e 2018e 2019e Cash Fund Services Receivables Underlying Revenue PPE Underlying Expenses Intangibles Underlying EBITDA Other Total assets Platform Services Payables Underlying Revenue Debt Underlying Expenses Provisions Underlying EBITDA Other Total liabilities Superannuation Trustee Services Shareholders equity Underlying Revenue Total shareholders funds Underlying Expenses Underlying EBITDA W/A diluted shares on issue Corporate Underlying Revenue * Our Cash NPAT adds back our estimate for acquisition related amortisation Underlying Expenses Note: Segmentals restated from FY16 onwards post Diversa consolidation Underlying EBITDA Remaining DVA Synergies SOURCE: BELL POTTER SECURITIES ESTIMATES Total Underlying Revenue Underlying Expenses Underlying EBITDA Page 6

7 Recommendation structure Buy: Expect >15% total return on a 12 month view. For stocks regarded as Speculative a return of >30% is expected. Research Team Staff Member TS Lim Sam Haddad Chris Savage Title/Sector Head of Research Phone tslim shaddad csavage Hold: Expect total return between -5% Jonathan Snape jsnape and 15% on a 12 month view Tim Piper tpiper Sell: Expect <-5% total return on a 12 month view John Hester Tanushree Jain Financials Healthcare Healthcare/Biotech jhester tnjain Speculative Investments are either start-up enterprises with nil or only prospective operations or recently commenced operations with only forecast cash flows, or companies that have commenced operations or have been in operation for some time but have only forecast cash flows and/or a stressed balance sheet. Such investments may carry an TS Lim Lafitani Sotiriou Peter Arden David Coates Duncan Hughes Associates James Filius Alexander McLean Banks/Regionals Diversified Financials Associate Analyst Associate Analyst tslim lsotiriou parden dcoates dhughes jfilius amclean exceptionally high level of capital risk and volatility of returns. Bell Potter Securities Limited ACN Level 38, Aurora Place 88 Phillip Street, Sydney 2000 Telephone The following may affect your legal rights. Important Disclaimer: This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. In Hong Kong this research is being distributed by Bell Potter Securities (HK) Limited which is licensed and regulated by the Securities and Futures Commission, Hong Kong. This is general investment advice only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives ( relevant personal circumstances ), a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the representative of such licensee, who has provided you with this report by arrangement with Bell Potter Securities Limited) should be made aware of your relevant personal circumstances and consulted before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Bell Potter Securities Limited has not verified independently the information contained in the document and Bell Potter Securities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Bell Potter Securities Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. Disclosure of interest: Bell Potter Securities Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document (which its representatives may directly share) and may from time to time hold interests in the securities referred to in this document. Lafitani Sotiriou owns 130,000 shares in OVH. ANALYST CERTIFICATION Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report. Page 7

OneVue Holdings (OVH)

OneVue Holdings (OVH) 24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)

More information

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions 16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously

More information

Platinum Asset Management (PTM)

Platinum Asset Management (PTM) 24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90

More information

Adacel Technologies (ADA)

Adacel Technologies (ADA) 9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously

More information

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES 9 February 2017 Analyst John O'Shea 613 9235 1633 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $4.80 Target (12 months) $5.73 (unchanged) Expected Return Capital growth

More information

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES 21 February 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) Growth Slowly Emerging In Europe Recommendation Hold (unchanged) Price $2.80 Target (12 months) $3.20

More information

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES 14 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Challenger (CGF) Expanding the potential Recommendation Buy (unchanged)

More information

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17. 29 June 2016 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Mayne Pharma (MYX) Merger Fallout Creates Opportunity Recommendation Buy (unchanged) Price $1.485 Target (12 months) $1.89

More information

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES Analyst John Hester 612 8224 2871 Cyclopharm (CYC) 5 March 2018 Speculative See key risks on Page 4 and Biotechnology Risk Warning on Page 7. Speculative securities may not be suitable for Retail Clients.

More information

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns 26 November 20 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 SurfStitch (SRF) Shaping the Surf industry Recommendation Buy (unchanged) Price $2.06 Target (12 months) $2.65 (previously

More information

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps 24 August 2018 TS Lim 612 8224 2810 Authorisation Tim Piper 612 8224 2825 Recommendation Buy (unchanged) Price $5.71 Target (12 months) $6.20 (previously $5.80) GICS Sector Banks Expected Return Capital

More information

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55 27 February 2017 Analyst John Hester 612 8224 2871 Authorisation Tanushree Jain 612 8224 2849 Recommendation Buy (unchanged) Price $0.415 Valuation $0.55 (unchanged) Risk Speculative GICS Sector Healthcare

More information

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES 16 January 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) US Market Continues To Expand Recommendation Hold (unchanged) Price $3.16 Target (12 months) $3.28

More information

Premier Investments (PMV)

Premier Investments (PMV) 16 March 2018 Analyst Sam Haddad 612 8224 2819 Authorisation Tim Piper 612 8224 2825 Premier Investments (PMV) Key growth pillars all strong Recommendation Buy (unchanged) Price $15.27 Target (12 months)

More information

Fortescue Metals Group Ltd (FMG)

Fortescue Metals Group Ltd (FMG) 3 March 2017 Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Fortescue Metals Group Ltd (FMG) All about the iron ore price Recommendation Sell (unchanged) Price $6.62 Target

More information

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES 17 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 ANZ Bank (ANZ) Unquestionably strong 1Q17 Recommendation Buy (Hold) Price $30.21 Target (12 months) $33.25 (previously

More information

ANZ Banking Group (ANZ)

ANZ Banking Group (ANZ) 1 May 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $27.47 Target (12 months) $30.20 (unchanged) GICS Sector Banks Expected Return Capital

More information

Aeon Metals Limited (AML)

Aeon Metals Limited (AML) Analyst David Coates 612 8224 2887 Authorisation Stuart Howe 613 9235 1856 Speculative See key risks on Page 4 Speculative securities may not be suitable for retail clients 22 March 2019 Aeon Metals Limited

More information

IPH Limited (IPH) Buy at the bottom

IPH Limited (IPH) Buy at the bottom 29 March 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 IPH Limited (IPH) Buy at the bottom Recommendation Buy (unchanged) Price $4.76 Target (12 months) $7.90 (unchanged) Expected

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 3 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.36 Target (12 months) $2.15 (unchanged) Expected Return Capital growth

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 6 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $30.39 Target (12 months) $32.50 (previously $30.00) Expected Return Capital growth

More information

Osprey Medical (OSP)

Osprey Medical (OSP) 18 October 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Osprey Medical (OSP) Harvey and Irma Curtail Growth Speculative See key risks on Page 5 and Biotechnology Risk Warning

More information

Commonwealth Bank (CBA)

Commonwealth Bank (CBA) 10 February 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Commonwealth Bank (CBA) Ordeal and triumph Recommendation Buy (unchanged) Price $74.20 Target (12 months) $83.50 (previously

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 16 July 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.655 Target (12 months) $0.95 (previously $0.98) Expected Return Capital growth

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 5 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.515 Target (12 months) $0.90 (previously $0.95) Expected Return Capital

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 19 April 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.76 Target (12 months) $0.98 (previously $1.00) Expected Return Capital growth

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $1.835 Valuation $3.35 (unchanged) -------------- Risk Speculative Expected Return Capital

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) 27 March 2018 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Galaxy Resources Ltd (GXY) Mt Cattlin doing what it is meant to Recommendation Buy Price $3.16 Price Target $4.75

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Speculative See key risks on Page 6. Speculative securities may not be suitable for retail clients 8 February 2019 Breaker NL (BRB) More

More information

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e 22 March 2017 Analyst Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Tech Sector Key picks unchanged: IRI, APX, ADA & IFM Stock Price Target Rating ADA $2.37 $3.25 Buy ALU $7.41 $7.90 Hold

More information

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt 4 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 (PPCHA) Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code Peet PPCHA Face value $100 Estimated

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 29 March 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $25.62 Target (12 months) $29.50 (unchanged) Expected Return Capital growth 15.1%

More information

FY 2018 results presentation

FY 2018 results presentation FY 2018 results presentation EMERGING FINANCIAL SERVICES COMPANY STRONGLY LEVERAGED TO SUPERANNUATION SECTOR, DELIVERS RECORD GROWTH OneVue Holdings Limited (OVH) 27 August 2018 1 HIGHLIGHTS Market leading

More information

OneVue Holdings Limited (OVH)

OneVue Holdings Limited (OVH) OneVue Holdings Limited (OVH) FY 2017 results presentation 28 August 2017 Regulators, fund managers and investors are calling for greater transparency of platform costs and revenue drivers Platform differentiation

More information

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt 7 March 2017 Analyst Tanushree Jain 612 8224 2849 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $1.90 Valuation $3.22 (previously $3.17) Risk Speculative GICS Sector Pharmaceuticals

More information

St George Mining Ltd (SGQ)

St George Mining Ltd (SGQ) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.225 Valuation $0.30 (previously $0.26) Risk Speculative Expected Return Capital growth

More information

Premier Investments (PMV)

Premier Investments (PMV) 4 April 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 Premier Investments (PMV) The Myers touch Recommendation Buy (unchanged) Price $14.20 Target (12 months) $17.65 (previously

More information

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD

More information

OneVue Holdings Limited (OVH)

OneVue Holdings Limited (OVH) OneVue Holdings Limited (OVH) H1 FY 2018 results presentation 26 February 2018 1 HIGHLIGHTS 2 FINANCIALS 3 OUTLOOK 4 APPENDICES Page 2 1 HIGHLIGHTS . BENEFITTING FROM SECTORAL GROWTH AND STRUCTURAL DISRUPTION

More information

Fortescue Metals Group (FMG)

Fortescue Metals Group (FMG) 30 October 2015 Analyst David Coates 612 8224 2887 Authorisation John Hester 612 8224 2871 Recommendation Buy (Hold) Price $2.09 Target (12 months) $2.40 (unchanged) Expected Return Capital growth 14.8%

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.41 Valuation $0.88 (previously $1.00) Risk Speculative Expected Return Capital growth

More information

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date 6 July 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 William Spraggett 613 9235 1733 Whitefield Resettable Preference Shares (WHFPB) Authorisation John Gleeson 612 9255 7220

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Recommendation Buy (unchanged) Price $0.315 Valuation $0.96 (previously $1.30) Risk Speculative GICS Sector Materials Expected

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 7 February 2017 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $2.25 Target (12 months) $2.60 Expected Return Capital growth 15.6% Dividend

More information

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality 26 September 2014 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Paragon Care (PGC) Big Boxes, Big Opportunity Recommendation Buy (Initiation) Price $0.33 Target (12 months) $0.38

More information

OneVue Holdings Limited (OVH)

OneVue Holdings Limited (OVH) OneVue Holdings Limited (OVH) Goldman Sachs Ninth Annual Small and Mid-Cap Conference Tuesday 17 April 2018 . BENEFITTING FROM SECTORAL GROWTH AND STRUCTURAL DISRUPTION Legislated superannuation growth

More information

Pioneer Credit (PNC)

Pioneer Credit (PNC) 23 June 2014 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 Pioneer Credit (PNC) Helping not chasing Recommendation Buy (Initiation) Price $1.55 Target (12 months) $1.80 Expected

More information

OneVue Holdings Limited (OVH)

OneVue Holdings Limited (OVH) OneVue Holdings Limited (OVH) Morgan Stanley Emerging Companies Conference Thursday 7 June 2018 A FINTECH COMPANY THAT PARTNERS TO DISRUPT ALONG THE SUPERANNUATION VALUE CHAIN Market leading businesses,

More information

Strike Energy Ltd (STX)

Strike Energy Ltd (STX) Analyst Peter Arden 613 9235 1833 Authorisation Stuart Howe 613 9235 1782 Recommendation Buy (unchanged) Price $0.115 Valuation $0.26 (previously $0.23) Risk Speculative Expected Return Capital growth

More information

Praemium (PPS) COMPANY REPORT. Quartermaster

Praemium (PPS) COMPANY REPORT. Quartermaster 10 October 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.45 SNAPSHOT Monthly Turnover $9.2mn Market Cap $162mn Shares Issued 399.6mn 52-Week High $0.54 52-Week

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 1 November 2016 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.38 Target (12 months) $2.10 (unchanged) Expected Return Capital growth

More information

Appendix 4D and Half-Year report 31 December FM deck

Appendix 4D and Half-Year report 31 December FM deck Appendix 4D and Half-Year report 31 December 2016 FM deck Appendix 4D and Half-Year Report 31 December 2016 1 Appendix 4D and Half-Year report 31 December 2016 Table of contents Appendix 4D... 3 Directors

More information

Aspire Mining Ltd (AKM)

Aspire Mining Ltd (AKM) 4 June 2012 Analyst Stuart Howe 613 9235 1782 Fred Truong 613 9235 1629 Authorisation Jonathan Snape 613 9235 1601 Aspire Mining Ltd (AKM) Ovoot PFS released Recommendation Buy (unchanged) Price $0.13

More information

Full Year Financial Results FY August 2015

Full Year Financial Results FY August 2015 Full Year Financial Results FY2015 25 August 2015 OneVue s Vision To deliver investors true choice and control ONEVUE S MISSION To provide digital gateways between investors and those that service them

More information

Value at the top end. Figure 1: Trading margins on debt and equity securities

Value at the top end. Figure 1: Trading margins on debt and equity securities 17 February 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Steve Goldberg 612 8224 2809 Westpac Convertible Preference Shares (WBCPC) Fixed Interest Issue overview

More information

SG Fleet Group. Another UK acquisition. Earnings and target price revision

SG Fleet Group. Another UK acquisition. Earnings and target price revision AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional

More information

Asset revaluation driven by almonds

Asset revaluation driven by almonds Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of

More information

Praemium (PPS) COMPANY REPORT. Model performance

Praemium (PPS) COMPANY REPORT. Model performance 14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board 9 November 2018 Analyst Tanushree Jain 612 8224 2849 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $2.18 Valuation $4.06 (previously $3.95) Risk Speculative GICS Sector Pharmaceuticals

More information

Resetting expectations

Resetting expectations Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp

More information

16-Jan Jul Oct Apr Sep Feb Dec Aug Nov May-09

16-Jan Jul Oct Apr Sep Feb Dec Aug Nov May-09 16-Mar-09 16-Apr-09 16-May-09 16-Jun-09 16-Jul-09 16-Aug-09 16-Sep-09 16-Oct-09 16-Nov-09 16-Dec-09 16-Jan-10 16-Feb-10 200 180 160 140 120 100 80 60 40 20 0 PJ 2014 2015 2016 2017 2018 2019 BG 90 60

More information

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS 23 November 2015 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Macquarie Group Capital Notes 2 (MQGPB) TS Lim 612 8224 2810 Fixed Interest Issue overview Issuer Issue

More information

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 17 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code BELL POTTER SECURITIES LIMITED ACN

More information

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

MEDICAL DEVELOPMENTS INTERNATIONAL LTD MEDICAL DEVELOPMENTS INTERNATIONAL LTD No pain in Germany HOLD Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals 6 April 2018 COMPANY UPDATE Ticker MVP Stock Price $7.10 Target Price $8.08

More information

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index

More information

1H 19 Investor Presentation February 2019

1H 19 Investor Presentation February 2019 1H 19 Investor Presentation February 2019 1 About Raiz Raiz (formerly Acorns) is a mobile first micro-investing platform via mobile phone or web app, which allows customers to invest in a portfolio of

More information

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates 11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST

More information

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%)

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%) 13 August 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation John Gleeson 612 9255 7220 Fixed Interest Issue overview Issuer Issue ASX code Crown CWNHA Face value $100

More information

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts Date Theme Company Update Company Noni B (NBL) SFH acquisition could be up to 6 EPS accretive Press reports today (Australian) suggest Noni B is a potential acquirer of Specialty Fashion Group (SFH), in

More information

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA ECX AU Price (at 02:49, 15 Dec 2016 GMT) Outperform A$3.77 Valuation - PER A$ 3.53-3.78 12-month target A$ 4.22 12-month TSR % +16.3 Volatility Index Low/Medium GICS sector Diversified Financials

More information

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016. AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium

More information

Bank of Queensland Capital Notes (BOQPE) Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Bank of Queensland Capital Notes (BOQPE) Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 23 November 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Bank of Queensland Capital Notes (BOQPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue

More information

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) 25 August 2017 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.235 Target (12 months) $0.60 (previously $0.67) Risk Speculative GICS

More information

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher. Delivering against expectations Z1P s Mar-18 qtrly report delivered well against our expectations. Positive operating cash flow for the qtr of $1.6m was a +$2.8m improvement qoq, despite the receivables

More information

Managed Accounts Holdings

Managed Accounts Holdings Managed Accounts Holdings MGP.ASX BUY Realised synergies drives profit above expectations The Underlying EBITDA exceeded the upper end of previous guidance, with continued organic growth and initial integration

More information

Consolidated Operations Group (COG)

Consolidated Operations Group (COG) Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA CDD AU Price (at 04:53, 17 Feb 2015 GMT) Neutral A$2.88 Valuation - Sum of Parts A$ 2.80-3.43 12-month target A$ 3.12 12-month TSR % +18.4 Volatility Index Medium GICS sector Capital Goods Market

More information

Platinum Asset Management

Platinum Asset Management AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium

More information

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities 8 February 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation (NABPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code NAB NABPE Face value $100

More information

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins. AUSTRALIA SGF AU Price (at 07:57, 27 Oct 2016 GMT) Outperform A$3.85 Valuation - PER A$ 3.92-4.18 12-month target A$ 4.37 12-month TSR % +18.1 Volatility Index Medium GICS sector Commercial & Professional

More information

ONEVIEW HEALTHCARE PLC

ONEVIEW HEALTHCARE PLC ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast

More information

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW COMPUMEDICS LTD HOLD CMP Downgrades FY17 Guidance Health Care Equipment & Services / Health Care Equipment 7 July 2017 COMPANY UPDATE Ticker CMP Stock Price $0.560 Target Price $0.530 Forecast Capital

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.29 Valuation $0.67 (previously $0.88) Risk Speculative Expected Return Capital growth

More information

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW WINDLAB LTD HOLD Lakeland financial close delayed again. Downgrade to HOLD. Utilities / Renewable Electricity 7 November 2018 COMPANY UPDATE Ticker WND Stock Price $1.180 Target Price $1.350 Forecast Capital

More information

Wisr Ltd (DirectMoney)

Wisr Ltd (DirectMoney) Wisr Ltd (DirectMoney) Interim result draws a line in the sand Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace-lending sector. The company has

More information

MNF Group Limited (MNF)

MNF Group Limited (MNF) MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market

More information

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged

More information

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SIV AU Price (at 08:50, 21 Mar 2017 GMT) Neutral A$7.71 Valuation - PER A$ 6.68 12-month target A$ 6.68 12-month TSR % -7.4 Volatility Index Medium GICS sector Capital Goods Market cap A$m 278

More information

FY18 RESULTS PERPETUAL LIMITED. Twelve months to 30 June Chris Green Interim Chief Executive Officer. Gillian Larkins Chief Financial Officer

FY18 RESULTS PERPETUAL LIMITED. Twelve months to 30 June Chris Green Interim Chief Executive Officer. Gillian Larkins Chief Financial Officer 30 August 2018 PERPETUAL LIMITED RESULTS Twelve months to 30 June 2018 Chris Green Interim Chief Executive Officer Gillian Larkins Chief Financial Officer ABN 86 000 431 827 CHRIS GREEN INTERIM CHIEF EXECUTIVE

More information

Regional Express Holdings Ltd REX

Regional Express Holdings Ltd REX 20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last

More information

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation BW EQUITIES RESEARCH 14 March 2017 Family Zone Cyber Safety Limited (FZO) Company Update BUY Rating: Target Price 1 : $0.46 Projected Return: 109% 1 12 month target Company Statistics Share Price (A$)

More information

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher Improved medium term cost guidance Z1P s Jun-18 qtrly update outlined a beat against our cash flow expectations, with the company having generated positive operating cash flow (after bad debts) for the

More information

Codan Limited (ASX: CDA)

Codan Limited (ASX: CDA) Codan Limited (ASX: CDA) 1H18 Results March 2018 WHO IS IIR?, IIR, is an independent investment research house based in Australia and the United States. IIR specialises in the analysis of high quality

More information

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2 21 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $0.37 Share Price $0.31 SNAPSHOT Monthly Turnover $2.5mn Market Cap $91mn Shares Issued 303.9mn 52-Week High $0.43 52-Week

More information

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team 24 March 2017 Crowd Mobile (CM8) A Strong FY17 Result 1. Crowd Mobile (CM8) delivered a strong set of FY17 results exceeding our revenue expectation by 3.3%, driven by an acceleration in fourth quarter

More information

Wisr Ltd (DirectMoney)

Wisr Ltd (DirectMoney) Wisr Ltd (DirectMoney) Strategic placement at 56% premium to previous close Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace lending sector. The

More information

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018 FY18 Results Presentation Bravura Solutions Limited 28 August 2018 Important notice and disclaimer The information contained in this document (including this notice) and discussed at this presentation

More information

Generation Healthcare REIT

Generation Healthcare REIT AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap

More information